Selected research
Market Analysis & Forecast
Global Antihelminthics Market Analysis and Forecast 2026-2032
Market perspective
The global Antihelminthics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Antihelminthics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Antihelminthics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Antihelminthics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Antihelminthics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Antihelminthics include Abbott, Sanofi, Sanofi, Johnson & Johnson, Novartis, Pfizer, GlaxoSmithKline, Bayer and AstraZeneca, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Antihelminthics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Antihelminthics, also provides the sales of main regions and countries. Of the upcoming market potential for Antihelminthics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Antihelminthics sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Antihelminthics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Antihelminthics sales, projected growth trends, production technology, application and end-user industry.
Antihelminthics Segment by Company
Abbott
Sanofi
Sanofi
Johnson & Johnson
Novartis
Pfizer
GlaxoSmithKline
Bayer
AstraZeneca
ZEISS International
Merck & Co.
Mentis Pharma
Astellas Pharma
ALLERGAN
Antihelminthics Segment by Type
Salicylanilides
Benzimidazoles
Praziquantel
Abamectin
Other
Antihelminthics Segment by Application
Ascariasis
Giardiasis
Fasciolasis
Filariasis
Angiostrongylosis
Schistosomiasis
Other
Antihelminthics Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antihelminthics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antihelminthics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antihelminthics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Antihelminthics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Antihelminthics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antihelminthics sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Salicylanilides
- Benzimidazoles
- Praziquantel
- Abamectin
- Other
Applications
- Ascariasis
- Giardiasis
- Fasciolasis
- Filariasis
- Angiostrongylosis
- Schistosomiasis
- Other
Companies covered
- Abbott
- Sanofi
- Sanofi
- Johnson & Johnson
- Novartis
- Pfizer
- GlaxoSmithKline
- Bayer
- AstraZeneca
- ZEISS International
- Merck & Co.
- Mentis Pharma
- Astellas Pharma
- ALLERGAN
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Antihelminthics Market by Type
- 1.2.1 Global Antihelminthics Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Salicylanilides
- 1.2.3 Benzimidazoles
- 1.2.4 Praziquantel
- 1.2.5 Abamectin
- 1.2.6 Other
- 1.3 Antihelminthics Market by Application
- 1.3.1 Global Antihelminthics Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Ascariasis
- 1.3.3 Giardiasis
- 1.3.4 Fasciolasis
- 1.3.5 Filariasis
- 1.3.6 Angiostrongylosis
- 1.3.7 Schistosomiasis
- 1.3.8 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Antihelminthics Market Dynamics
- 2.1 Antihelminthics Industry Trends
- 2.2 Antihelminthics Industry Drivers
- 2.3 Antihelminthics Industry Opportunities and Challenges
- 2.4 Antihelminthics Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Antihelminthics Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Antihelminthics Revenue by Region
- 3.2.1 Global Antihelminthics Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Antihelminthics Revenue by Region (2021-2026)
- 3.2.3 Global Antihelminthics Revenue by Region (2027-2032)
- 3.2.4 Global Antihelminthics Revenue Market Share by Region (2021-2032)
- 3.3 Global Antihelminthics Sales Estimates and Forecasts 2021-2032
- 3.4 Global Antihelminthics Sales by Region
- 3.4.1 Global Antihelminthics Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Antihelminthics Sales by Region (2021-2026)
- 3.4.3 Global Antihelminthics Sales by Region (2027-2032)
- 3.4.4 Global Antihelminthics Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Antihelminthics Revenue by Manufacturers
- 4.1.1 Global Antihelminthics Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Antihelminthics Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Antihelminthics Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Antihelminthics Sales by Manufacturers
- 4.2.1 Global Antihelminthics Sales by Manufacturers (2021-2026)
- 4.2.2 Global Antihelminthics Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Antihelminthics Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Antihelminthics Sales Price by Manufacturers (2021-2026)
- 4.4 Global Antihelminthics Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Antihelminthics Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Antihelminthics Manufacturers, Product Type & Application
- 4.7 Global Antihelminthics Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Antihelminthics Market CR5 and HHI
- 4.8.2 2025 Antihelminthics Tier 1, Tier 2, and Tier 3
5 Antihelminthics Market by Type
- 5.1 Global Antihelminthics Revenue by Type
- 5.1.1 Global Antihelminthics Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Antihelminthics Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Antihelminthics Revenue Market Share by Type (2021-2032)
- 5.2 Global Antihelminthics Sales by Type
- 5.2.1 Global Antihelminthics Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Antihelminthics Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global Antihelminthics Sales Market Share by Type (2021-2032)
- 5.3 Global Antihelminthics Price by Type
6 Antihelminthics Market by Application
- 6.1 Global Antihelminthics Revenue by Application
- 6.1.1 Global Antihelminthics Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Antihelminthics Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Antihelminthics Revenue Market Share by Application (2021-2032)
- 6.2 Global Antihelminthics Sales by Application
- 6.2.1 Global Antihelminthics Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Antihelminthics Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global Antihelminthics Sales Market Share by Application (2021-2032)
- 6.3 Global Antihelminthics Price by Application
7 Company Profiles
- 7.1 Abbott
- 7.1.1 Abbott Company Information
- 7.1.2 Abbott Business Overview
- 7.1.3 Abbott Antihelminthics Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Abbott Antihelminthics Product Portfolio
- 7.1.5 Abbott Recent Developments
- 7.2 Sanofi
- 7.2.1 Sanofi Company Information
- 7.2.2 Sanofi Business Overview
- 7.2.3 Sanofi Antihelminthics Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Sanofi Antihelminthics Product Portfolio
- 7.2.5 Sanofi Recent Developments
- 7.3 Sanofi
- 7.3.1 Sanofi Company Information
- 7.3.2 Sanofi Business Overview
- 7.3.3 Sanofi Antihelminthics Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Sanofi Antihelminthics Product Portfolio
- 7.3.5 Sanofi Recent Developments
- 7.4 Johnson & Johnson
- 7.4.1 Johnson & Johnson Company Information
- 7.4.2 Johnson & Johnson Business Overview
- 7.4.3 Johnson & Johnson Antihelminthics Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Johnson & Johnson Antihelminthics Product Portfolio
- 7.4.5 Johnson & Johnson Recent Developments
- 7.5 Novartis
- 7.5.1 Novartis Company Information
- 7.5.2 Novartis Business Overview
- 7.5.3 Novartis Antihelminthics Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Novartis Antihelminthics Product Portfolio
- 7.5.5 Novartis Recent Developments
- 7.6 Pfizer
- 7.6.1 Pfizer Company Information
- 7.6.2 Pfizer Business Overview
- 7.6.3 Pfizer Antihelminthics Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Pfizer Antihelminthics Product Portfolio
- 7.6.5 Pfizer Recent Developments
- 7.7 GlaxoSmithKline
- 7.7.1 GlaxoSmithKline Company Information
- 7.7.2 GlaxoSmithKline Business Overview
- 7.7.3 GlaxoSmithKline Antihelminthics Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 GlaxoSmithKline Antihelminthics Product Portfolio
- 7.7.5 GlaxoSmithKline Recent Developments
- 7.8 Bayer
- 7.8.1 Bayer Company Information
- 7.8.2 Bayer Business Overview
- 7.8.3 Bayer Antihelminthics Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Bayer Antihelminthics Product Portfolio
- 7.8.5 Bayer Recent Developments
- 7.9 AstraZeneca
- 7.9.1 AstraZeneca Company Information
- 7.9.2 AstraZeneca Business Overview
- 7.9.3 AstraZeneca Antihelminthics Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 AstraZeneca Antihelminthics Product Portfolio
- 7.9.5 AstraZeneca Recent Developments
- 7.10 ZEISS International
- 7.10.1 ZEISS International Company Information
- 7.10.2 ZEISS International Business Overview
- 7.10.3 ZEISS International Antihelminthics Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 ZEISS International Antihelminthics Product Portfolio
- 7.10.5 ZEISS International Recent Developments
- 7.11 Merck & Co.
- 7.11.1 Merck & Co. Company Information
- 7.11.2 Merck & Co. Business Overview
- 7.11.3 Merck & Co. Antihelminthics Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 Merck & Co. Antihelminthics Product Portfolio
- 7.11.5 Merck & Co. Recent Developments
- 7.12 Mentis Pharma
- 7.12.1 Mentis Pharma Company Information
- 7.12.2 Mentis Pharma Business Overview
- 7.12.3 Mentis Pharma Antihelminthics Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.12.4 Mentis Pharma Antihelminthics Product Portfolio
- 7.12.5 Mentis Pharma Recent Developments
- 7.13 Astellas Pharma
- 7.13.1 Astellas Pharma Company Information
- 7.13.2 Astellas Pharma Business Overview
- 7.13.3 Astellas Pharma Antihelminthics Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.13.4 Astellas Pharma Antihelminthics Product Portfolio
- 7.13.5 Astellas Pharma Recent Developments
- 7.14 ALLERGAN
- 7.14.1 ALLERGAN Company Information
- 7.14.2 ALLERGAN Business Overview
- 7.14.3 ALLERGAN Antihelminthics Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.14.4 ALLERGAN Antihelminthics Product Portfolio
- 7.14.5 ALLERGAN Recent Developments
8 North America
- 8.1 North America Antihelminthics Market Size by Type
- 8.1.1 North America Antihelminthics Revenue by Type (2021-2032)
- 8.1.2 North America Antihelminthics Sales by Type (2021-2032)
- 8.1.3 North America Antihelminthics Price by Type (2021-2032)
- 8.2 North America Antihelminthics Market Size by Application
- 8.2.1 North America Antihelminthics Revenue by Application (2021-2032)
- 8.2.2 North America Antihelminthics Sales by Application (2021-2032)
- 8.2.3 North America Antihelminthics Price by Application (2021-2032)
- 8.3 North America Antihelminthics Market Size by Country
- 8.3.1 North America Antihelminthics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Antihelminthics Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Antihelminthics Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
9 Europe
- 9.1 Europe Antihelminthics Market Size by Type
- 9.1.1 Europe Antihelminthics Revenue by Type (2021-2032)
- 9.1.2 Europe Antihelminthics Sales by Type (2021-2032)
- 9.1.3 Europe Antihelminthics Price by Type (2021-2032)
- 9.2 Europe Antihelminthics Market Size by Application
- 9.2.1 Europe Antihelminthics Revenue by Application (2021-2032)
- 9.2.2 Europe Antihelminthics Sales by Application (2021-2032)
- 9.2.3 Europe Antihelminthics Price by Application (2021-2032)
- 9.3 Europe Antihelminthics Market Size by Country
- 9.3.1 Europe Antihelminthics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Antihelminthics Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Antihelminthics Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
- 9.3.9 Nordic Countries
10 China
- 10.1 China Antihelminthics Market Size by Type
- 10.1.1 China Antihelminthics Revenue by Type (2021-2032)
- 10.1.2 China Antihelminthics Sales by Type (2021-2032)
- 10.1.3 China Antihelminthics Price by Type (2021-2032)
- 10.2 China Antihelminthics Market Size by Application
- 10.2.1 China Antihelminthics Revenue by Application (2021-2032)
- 10.2.2 China Antihelminthics Sales by Application (2021-2032)
- 10.2.3 China Antihelminthics Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Antihelminthics Market Size by Type
- 11.1.1 Asia Antihelminthics Revenue by Type (2021-2032)
- 11.1.2 Asia Antihelminthics Sales by Type (2021-2032)
- 11.1.3 Asia Antihelminthics Price by Type (2021-2032)
- 11.2 Asia Antihelminthics Market Size by Application
- 11.2.1 Asia Antihelminthics Revenue by Application (2021-2032)
- 11.2.2 Asia Antihelminthics Sales by Application (2021-2032)
- 11.2.3 Asia Antihelminthics Price by Application (2021-2032)
- 11.3 Asia Antihelminthics Market Size by Country
- 11.3.1 Asia Antihelminthics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Antihelminthics Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Antihelminthics Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Antihelminthics Market Size by Type
- 12.1.1 SAMEA Antihelminthics Revenue by Type (2021-2032)
- 12.1.2 SAMEA Antihelminthics Sales by Type (2021-2032)
- 12.1.3 SAMEA Antihelminthics Price by Type (2021-2032)
- 12.2 SAMEA Antihelminthics Market Size by Application
- 12.2.1 SAMEA Antihelminthics Revenue by Application (2021-2032)
- 12.2.2 SAMEA Antihelminthics Sales by Application (2021-2032)
- 12.2.3 SAMEA Antihelminthics Price by Application (2021-2032)
- 12.3 SAMEA Antihelminthics Market Size by Country
- 12.3.1 SAMEA Antihelminthics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Antihelminthics Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Antihelminthics Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Antihelminthics Value Chain Analysis
- 13.1.1 Antihelminthics Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Antihelminthics Production Mode & Process
- 13.2 Antihelminthics Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Antihelminthics Distributors
- 13.2.3 Antihelminthics Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst